2478-10-6C=CC(=O)OCCCCONDWUBGAGUCISDV-UHFFFAOYSA-N2478-10-6、51309-28-5DTXSID3044623CHEMBL3189040Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 2.6% (9 of 350) of reports.
Danger
H302 (95.7%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 350 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: 2-Propenoic acid, 4-hydroxybutyl ester
REACH registered substance: 4-hydroxybutyl acrylate (EC: 219-606-3)
2-Propenoic acid, 4-hydroxybutyl ester: Does not have an individual approval but may be used under an appropriate group standard
UsesHydroxybutyl acrylate was one of the monomers utilized in the preparation of poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membranes.
General Description4-Hydroxybutyl acrylate (HBA) can be synthesized by the esterification of acrylic acid with 1, 4 butanediol over a catalyst such as Amberlyst 15. 4-Hydroxybutyl acrylate (HBA) exhibits properties such as luster, chemical and scratch resistance. HBA monomers may be used as one of the constituents for the fabrication of a membrane system for controlled release of transdermal drug delivery system.
Preparation4-Hydroxybutylacrylate can be prepared by a condensation reaction of acryloyl chloride and butanediol compounds. It should be noted that this reaction requires strict control of the stoichiometric ratio to prevent the diacylation side reaction of butanediol.
Loading…